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Background. Current estimates for causes of childhood deaths are mainly premised on modeling of vital registration and lim-
ited verbal autopsy data and generally only characterize the underlying cause of death (CoD). We investigated the potential of min-
imally invasive tissue sampling (MITS) for ascertaining the underlying and immediate CoD in children 1 month to 14 years of age.
Methods. MITS included postmortem tissue biopsies of brain, liver, and lung for histopathology examination; microbial culture 
of blood, cerebrospinal fluid (CSF), liver, and lung samples; and molecular microbial testing on blood, CSF, lung, and rectal swabs. 
Each case was individually adjudicated for underlying, antecedent, and immediate CoD by an international multidisciplinary team 
of medical experts and coded using the International Classification of Diseases, Tenth Revision (ICD-10).
Results. An underlying CoD was determined for 99% of 127 cases, leading causes being congenital malformations (18.9%), complica-
tions of prematurity (14.2%), human immunodeficiency virus/AIDS (12.6%), diarrheal disease (8.7%), acute respiratory infections (7.9%), 
injuries (7.9%), and malignancies (7.1%). The main immediate CoD was pneumonia, sepsis, and diarrhea in 33.9%, 19.7%, and 10.2% of 
cases, respectively. Infection-related deaths were either an underlying or immediate CoD in 78.0% of cases. Community-acquired pneu-
monia deaths (n = 32) were attributed to respiratory syncytial virus (21.9%), Pneumocystis jirovecii (18.8%), cytomegalovirus (15.6%), 
Klebsiella pneumoniae (15.6%), and Streptococcus pneumoniae (12.5%). Seventy-one percent of 24 sepsis deaths were hospital-acquired, 
mainly due to Acinetobacter baumannii (47.1%) and K. pneumoniae (35.3%). Sixty-two percent of cases were malnourished.
Conclusions. MITS, coupled with antemortem clinical information, provides detailed insight into causes of childhood deaths 
that could be informative for prioritization of strategies aimed at reducing under-5 mortality.
Keywords. child mortality; minimally invasive tissue sampling; pneumonia; diarrhea; South Africa.
Global mortality rates in children aged 28 days to 1 year and 
1–5  years have declined between 2000 and 2015 at an annu-
alized rate of 2.8% and 3.5%, respectively, including 4.4% and 
5.4% in respective age groups in sub-Saharan Africa [1, 2]. 
Current estimates on causes of under-5 childhood deaths are 
largely premised on modeling using vital registration data 
coupled with limited verbal autopsy data (approximately 1 per 
850 deaths) [3], exposure prevalence, and risk-attribution fac-
tors [3, 4]. Furthermore, the estimates on causes of childhood 
deaths are mainly focused on the underlying medical condi-
tion that likely led to the sequence of events resulting in death. 
This could undermine recognition of more immediate medical 
events that resulted in the death, which might otherwise be pre-
ventable or for which interventions can be developed. The cur-
rent dependency on verbal autopsy data, a nonspecific method 
for cause of death (CoD) attribution, argues for more objective 
and granular understanding of specific immediate causes of 
death in low- and middle-income countries (LMICs).
Complete diagnostic autopsy is the “gold standard” for ascer-
taining CoD, but is rarely undertaken in LMICs due to limited 
resources, cost constraints, and cultural and religious barriers 
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on acceptability [5, 6]. Minimally invasive tissue sampling 
(MITS), also known as minimally invasive autopsy, involves 
postmortem collection of fluid and solid tissue samples using 
biopsy needles. Community engagement studies have sug-
gested that MITS would be theoretically culturally acceptable in 
African and South Asian countries [6]. Furthermore, a valida-
tion study undertaken in Mozambique demonstrated moderate 
concordance (κ = 0.75) in CoD attribution between complete 
diagnostic autopsy and MITS in children >1 month of age [7].
We aimed to evaluate the acceptability and utility of MITS, 
as proof of concept, in ascertaining the causal pathway of death 
in children >1 month of age in an LMIC setting (Soweto, South 
Africa).
METHODS
Study Site and Population
The study was conducted from 29 June 2015 to 1 August 2016 
at Chris Hani Baragwanath Academic Hospital (CHBAH). 
Further details of the study site, including healthcare setting 
and human immunodeficiency virus (HIV) prevalence, are 
given in the companion manuscript on neonatal deaths, also 
published in this supplement [8]. Additionally, in South Africa, 
the Expanded Programme on Immunization includes pneumo-
coccal conjugate vaccine (PCV) and rotavirus vaccine that have 
been introduced since 2009, in addition to 8 other routinely ad-
ministered childhood vaccines [9].
Study Design and Procedures
In this prospective, observational study, deaths of children 
<14 years of age occurring in the medical and emergency depart-
ment of CHBAH, and those certified as dead upon arrival at the 
hospital, were identified through daily screening of death regis-
tries, excluding from 18 December 2015 to 3 January 2016 (va-
cation period). We initiated the study by initially only screening 
and enrolling deaths occurring in the general medical wards. The 
surveillance and enrollment of cases was expanded to include 
deaths occurring in the surgical burn unit (31 August 2015), he-
matology/oncology ward (16 September 2015), surgical wards 
(30 September 2015), and the nursery ward for care of stable very 
low-birth-weight infants (kangaroo-care facility; 7 October 2015). 
Details on the counseling and consenting processes are as detailed 
elsewhere in the companion paper on neonatal deaths [8].
We aimed to undertake MITS within 24 hours of death and 
excluded those cases in which the procedure could not be per-
formed within 72 hours. Corpses were kept in the hospital mor-
tuary at 4°C until retrieval for burial.
Minimally Invasive Tissue Sampling
Trained study staff (medical doctor or professional nurse as-
sisted by research assistants) undertook MITS as detailed else-
where in this supplement [8]. The testing algorithm for the 
collected samples was similar to that done in neonatal deaths, 
with the exception that molecular testing of blood samples 
using the FastTrack Diagnostics (FTD; Sliema, Malta) neo-
natal sepsis kit was not undertaken in the age group 1 month to 
14 years; and only the FTD Respiratory-33 panel kit was used 
on lung samples. Methods used for tissue histology processing 
are also described elsewhere in this supplement [8].
Determination of Cause of Death
The CoD attribution was based on consensus of an interna-
tional panel convened in South Africa from 26 March to 5 
April 2017 composed of pathologists, pediatricians, epidemi-
ologists, microbiologists, obstetricians, infectious disease spe-
cialists, and international coding and certification experts (the 
Determination of Cause of Death [DeCoDe] panel group is 
listed in the Acknowledgements). The panel, chaired by either 
Chris Wilson or Scott Dowell, deliberated on CoD attribution 
using the International Classification of Diseases, Tenth Revision 
(ICD-10) [10]. This included attributing a single underlying 
medical condition that likely initiated the sequence of events 
culminating in death, and the most proximal event (ie, imme-
diate cause) of death, if applicable. Also evaluated were any 
antecedent conditions in the casual pathway leading to death, 
and medical conditions considered to have a contributory role, 
but not directly involved in the causal pathway. Details on the 
working methods of the DeCoDe panel are described in the 
companion manuscript on causes of neonatal deaths [8]. The 
DeCoDe panel allowed for inclusion of two “immediate” CoD, 
where concurrent diseases could not be prioritized as the main 
condition that caused the death; for example, histologically 
confirmed Pneumocytis jirovecii and respiratory syncytial virus 
(RSV) pneumonitis being concurrently present (and attributed 
as the immediate CoD) in a child with underlying HIV infec-
tion (attributed as the underlying CoD).
The CoD was generally based on consensus, in the absence of 
which a majority viewpoint was used, and recorded according 
to World Health Organization (WHO) guidelines for death cer-
tification. In addition, CoD was stratified into first-level United 
Nations Inter-agency Group on Child Mortality Estimation 
(UN-IGME) categories [11]: group I  (an aggregation of com-
municable, maternal, perinatal, and nutritional conditions), 
group II (noncommunicable diseases), and group III (injuries).
Statistical Analysis
We stratified analyses to infants (1–11  months of age), chil-
dren (12–59 months of age), and older children (60 months to 
14 years of age). Descriptive statistics were calculated providing 
medians with interquartile ranges for continuous variables, and 
proportions for categorical variables. For select variables, dif-
ferences between the infants, children, and older children were 
tested using Kruskal-Wallis or Fisher exact test. Weight-for-age 
was calculated in Stata software using the UK WHO Preterm 
Growth Charts (version UKWHOpreterm) and UK WHO 
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Term Growth Charts (version UKWHOterm) for the preterm 
babies and children aged 0–20  years, respectively. Statistical 
analysis was done using Stata software version 15 (StataCorp, 
College Station, Texas).
Ethical Considerations
The University of the Witwatersrand Human Research Ethics 
Committee (number 150215) and the CHBAH Protocol Review 
Committee approved the study. Parents/legal guardians pro-
vided consent prior to any MITS study procedure.
RESULTS
There were 412 deaths among children aged 1 month to 14 years 
at CHBAH during the study period. Sixty percent (n = 247) of 
the deaths were screened for study participation, while 165 
(40%) cases were not screened mainly due to the timing of 
phasing in of enrollment in the nonmedical wards (Figure 1). 
Seven of the 247 (2.8%) screened cases were ineligible, and in 
19.2% cases the parents could not be contacted within 72 hours 
of death. Of the remaining 194 screened cases, 127 (65.5%) con-
sented to study participation, including 14 of 127 (11.0%) who 
were certified dead upon hospital arrival.
The median age of enrolled cases was 11  months; 52.8% 
were infants, 29.1% children, and 18.1% older children. The 
median time from hospital admission to death was 3.0  days. 
MITS sampling was done at a median of 20.2 (11.3–27.6) hours 
after death. Overall, 36.4% of cases were born to women living 
with HIV; however, only 12.8% of cases were confirmed to be 
HIV infected on postmortem HIV polymerase chain reaction 
testing. Overall, 62.4% of cases, including 71.7% of infants, were 
malnourished. Sixteen percent of cases had underlying congen-
ital abnormalities. Approximately 20% of the cases had been ad-
mitted for mechanical ventilation support in the intensive care 
unit (Table 1).
MITS Tissue Adequacy
For solid tissues, most tissue biopsy samples were graded as ad-
equate: 71.6% (n = 91) for left lung, 77.2% (n = 98) for right 
lung, 81.9% (n = 104) for brain, and 84.2% (n = 107) for liver; 
or as suboptimal: 8.7% (n = 11) for liver, 11% (n = 14) for brain, 
15.7% (n = 20) for right lung, and 19.7% (n = 25) for left lung. 
No target organ tissue was obtained in 5.5% (n  =  7) of liver, 
7.1% (n = 9) of right lung and brain, and 8.7% (n = 11) of left 
lung samples.
Cause of Death Attribution
Using the findings from the molecular testing, microbiology, 
and histopathology in addition to the antemortem clinical find-
ings, the DeCoDe panel assigned a CoD in 99% of cases. Details 
of the certainty of diagnoses for the different underlying CoD 
and immediate CoD categories are reported in Supplementary 
Tables 1 and 2. The DeCoDe panel was confident (level 1) for 
the majority of underlying (81.1%) and immediate CoD 
(77.2%) diagnoses. Overall, the UN-IGME categories for un-
derlying CoD were 55.1% due to communicable diseases, ma-
ternal, perinatal, and nutritional conditions (group 1), 36% due 
to noncommunicable diseases (group 2), and 8% due to injuries 
(group 3) (Tables 2 and 3; Figure 2). In group I, these included 
deaths attributed to underlying HIV/AIDS (22.9%), diarrheal 
disease (15.7%), acute respiratory infections (14.3%), and com-
plications of prematurity (14.2%).
Among cases with HIV as the underlying CoD (n = 16), infec-
tion was the immediate CoD in 15 (93.8%) cases, mainly from 
pneumonia and sepsis (n = 7 [43.8%] and n = 4 [25.0%], respec-
tively; Figure 3; Table 2). Similarly, infections were also the im-
mediate CoD in 83.3% of 18 deaths attributed to complications 
of prematurity as the underlying cause, also mainly due to pneu-
monia (n = 9 [50.0%]) or sepsis (n = 5 [27.8%]) (Figure 3; Table 2).
Among the 10 cases with acute respiratory infections as the 
underlying CoD, 8 deaths were due to the pneumonia caused 
by RSV (n = 2), Streptococcus pneumoniae (n = 2), Haemophilus 
Missed deaths:
Total childhood
Deaths:
Deaths ineligible
Not approached: Consent declined:
Figure 1. Flow diagram showing death notifications at the Chris Hani 
Baragwanath Academic Hospital of children aged 1  month to 14  years, and 
screening and enrollment of cases into the minimally invasive tissue sampling study. 
aDeaths were missed because the initial surveillance was limited to the pediatric 
medical wards, high care unit, and casualty (emergency ward). The surveillance 
was later extended to the burns unit (on 31 August 2015), hematology/oncology 
ward (16 September 2015), surgical ward (30 September 2015), and the neonatal 
kangaroo-care nursing ward (7 October 2015) to capture all childhood deaths at the 
facility. bIneligible cases included a medico-legal death (n = 1), a case from outside 
Soweto (n = 1), those with no legal guardian (n = 2), and cases where both parents 
were minors (n = 3). cWe enrolled cases on all days, excluding weekends and public 
holidays, from 19 December 2015 to 2 January 2016, during which time 24 cases 
were not approached for consenting. Additionally, 4 children were buried at the 
time of contact and we could not contact the parents of 18 cases within 72 hours 
of death. dMost parents did not provide a reason for declining study participation 
(n = 51 [76.1%]). Reasons cited for nonparticipation included cultural reasons (n = 9 
[13.4%]), parental belief that they were aware of the cause of death (n = 3 [4.5%]), 
and parental feeling of the child already having suffered (n = 4 [6.0%]).
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influenzae (n  =  1), Staphylococcus aureus (n  =  1), P.  jirovecii 
(n = 1), and influenza A virus (n = 1). Similarly, 10 of 11 (90.9%) 
deaths attributed to diarrhea as the underlying cause died as 
a consequence thereof, whereas 1 child died of community-
acquired Escherichia coli sepsis. The diarrhea deaths were due 
to enteroinvasive E. coli/Shigella (n = 4) and norovirus (n = 1), 
while in 6 cases no pathogen was identified. Details of other 
group 1 underlying CoD are outlined in Table 3 and included 
3 (2.4%) deaths due to tuberculosis, 2 (1.6%) due to hepatitis 
A, and 1 each from varicella and congenital rubella syndrome.
The majority of UN-IGME group II (n = 46) category deaths 
were attributed to congenital malformations (n = 24 [18.9% of 
overall deaths]) of which 70.8% were in infants and 25.0% in 
children (Table 3). The most frequent congenital abnormal-
ities were gastrointestinal malformations (37.5%), Trisomy-21 
(25%), and cardiovascular system malformations (25%) (Table 
3). Infections were also the dominant immediate CoD among 
cases with underlying congenital abnormalities, including 45.8% 
(n = 11) pneumonia, 20.8% (n = 5) sepsis, and 4.2% (n = 1) men-
ingitis (Figure 3; Table 2). Among these infection-related deaths 
(n = 17), 58.8% (n = 10) were community-associated, and 41.2% 
(n = 7) were hospital-acquired. Malignancies were diagnosed as 
an underlying CoD in 7.1% of case overall, and contributed to 
40.9% (19/43) of UN-IGME group II deaths (Table 2).
The majority of deaths classified as UN-IGME group III 
(n = 10) occurred in children (60%) and older children (30%). 
These included deaths from burns (n = 4 [40.0%]), poisoning 
(n  =  3 [30.0%]), foreign body asphyxiation (n  =  1 [10.0%]), 
drowning (n = 1 [10.0%]), and motor vehicle accident (n = 1 
[10.0%]) (Table 3). Among the group III deaths, hospital-
acquired infection was the immediate CoD in 40.0% of cases, 
and community-acquired infection in 10.0% (Figure 3; Table 2).
Overall Contribution of Infections Either as an Immediate or Underlying 
Cause of Death
Overall, infections were attributed as an underlying or imme-
diate cause in 78% (n = 99) of deaths. This included 48 of 127 
(37.8%) cases where infection was an underlying CoD, and 51 
cases where the underlying CoD was a noninfectious medical 
condition (64.6% of 79).
Pneumonia was the commonest infection-related CoD (44% 
[n  =  44/99]), 73% (n  =  32/44) of which were community-
associated and 27% (n  =  12/44) hospital-acquired (Table 4). 
Among community-associated pneumonia cases (n = 32), RSV 
was the most commonly implicated pathogen (21.9% [n = 7]) 
and occurred exclusively among infants, including 4 cases in 
children with a noninfectious underlying CoD. Other patho-
gens causing community-acquired pneumonia deaths were 
P. jirovecii (18.8% [n = 6]), including 3 in HIV-infected children 
and 3 in infants without HIV infection, 1 of whom had under-
lying cerebral palsy, another was HIV exposed; the third was 
HIV unexposed and nutritional status was unknown. Other 
Table 1. Demographic Features of Childhood Deaths in Which Minimally Invasive Tissue Sampling Was Undertaken
Features
Total
Infants   
(1–11 mo)
Children   
(12–59 mo)
Older Children  
(≥60 mo)
(N = 127) (n = 67) (n = 37) (n = 23)
Median age at death, mo (IQR) 11.0 (2.6–26.9) 2.7 (1.8–5.7) 19.2 (13.7–26.5) 97.9 (77.1–105.2)
Male sex, No. (%) 64 (50.4) 31 (46.3) 22 (59.5) 11 (47.8)
HIV exposeda,b, no./No (%) 40/110 (36.4) 26/64 (40.6) 9/30 (30.0) 5/16 (31.3)
HIV infectedc, no./No (%) 16/125 (12.8) 9 (13.4) 3 (8.1) 4/21 (19.0)
Median weight, kg at admission (IQR) 5.1 (2.5–9.3) 2.8 (1.4–4.5) 8.7 (6–10) 17.3 (14.1–22.6)
Weight for aged z score < –2, no./No (%) 53/85 (62.4) 33/46 (71.7) 14/27 (51.9) 6/12 (50.0)
Median No. of days between admission and death (IQR) 3 (0–28) 7 (0–40) 1 (0–4) 5 (1–12)
Median time between death and MITS done, h 20.2 (11.3–27.6) 23.0 (14.3–28.2) 18.0 (7.0–24.1) 16.6 (11.7–28.0)
Congenital abnormalities presente, No. (%) 20 (15.7) 13 (19.4) 5 (13.5) 2 (8.7)
Mechanical ventilation support during hospitalizationf, no./No (%) 21/103 (20.4) 19/53 (35.9) 2/31 (6.5) 0/19 (0.0)
Days spent in ICUg (IQR) 32 (11–54) 32 (11–62) 19 (4–34) Not applicable
Time to death between ICU discharge and death, d 0 (0–1) 0 (0–1) 9 (0–18) Not applicable
Abbreviations: HIV, human immunodeficiency virus; ICU, intensive care unit; IQR, interquartile range; MITS, minimally invasive tissue sampling.
aHIV exposed includes children born to HIV-infected mothers or children who were HIV polymerase chain reaction negative but HIV enzyme-linked immunosorbent assay positive.
bHIV exposure could not be ascertained in 17 of the 127 cases.
cNo HIV result in 2 cases. One case was born to an HIV-uninfected woman and the HIV exposure status of the other case was unknown.
dUnited Kingdom (UK) World Health Organization (WHO) preterm and term growth charts were used to calculate z scores for the preterm babies and children 0–20 years, respectively.
eThe congenital malformations were identified from the case notes or during the MITS procedure. These included 6 cases of hydrocephalus (3 in infants, 1 in children, and 2 in older children), 
1 of which also had other additional malformations of Hirchsprung disease (1 infant). Three cases had Down syndrome (1 infant and 2 children); 2 cases had unspecified dysmorphic features 
including 1 with cleft palate (both infants); and 1 case each had exomphalos with jejunal atresia (infant), anorectal malformations (child), biliary atresia (child), duodenal atresia with patent 
ductus arteriosus (infant), jejunal atresia (infant), gastroschisis (infant), choanal atresia with patent ductus arteriosus (infant), spina bifida (child), and transposition of great vessels (child).
fThere were no records in 24 cases to identify whether the child received mechanical ventilation. Mechanical ventilation modalities included 8 cases that received continuous positive airway 
pressure (7 infants and 1 child), 7 positive end pressure (6 infants and 1 child), 4 unspecified ventilation type (4 infants), and 1 each of high-frequency oscillatory ventilation (1 infant) and 
intermittent positive-pressure ventilation (1 infant).
gMedian duration of stay for those children who were admitted to ICU.
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Table 2. Underlying and Immediate Cause of Death Attribution in Infants (1–11 Months of Age), Children (12–59 Months of Age), and Older Children (60 
Months–14 Years of Age)
Global Burden of Disease Categorya Total (N = 127) Infants (n = 67) Children (n = 37) Older Children (n = 23)
Group I (communicable, maternal, perinatal, and nutritional conditions): 70 (55.1) 43 (64.2) 21 (56.8) 6 (26.1)
Acute respiratory infections 10 (7.9) 4 (6.0) 6 (16.2) 0 (0.0)
 Community-acquired pneumoniab 8 (6.3) 3 (4.5) 5 (13.5) 0 (0.0)
 Myocarditis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Rotavirus enteritisc 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Birth asphyxia and trauma 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 Nosocomial pneumonia 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Hyperosmolality and hypernatremia 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Diarrhea 11 (8.7) 6 (9.0) 4 (10.8) 1 (4.4)
 Gastroenteritis 10 (7.8) 6 (8.8) 4 (10.8) 0 (0.0)
 Sepsis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
HIV/AIDS 16 (12.6) 9 (13.4) 4 (10.4) 3 (13.0)
 Community-acquired pneumonia 6 (4.7) 4 (6.0) 1 (2.7) 1 (4.4)
 Nosocomial-acquired pneumonia 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Community-acquired sepsis 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Nosocomial-acquired sepsis 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Gastroenteritis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Meningitis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Encephalitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Heart failure 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Miliary tuberculosis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Meningitis/encephalitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Meningitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Prematurity 18 (14.2) 18 (26.9) 0 (0.0) 0 (0.0)
 Community-acquired pneumonia 4 (3.2) 4 (7.5) 0 (0.0) 0 (0.0)
 Nosocomial-acquired pneumonia 5 (3.9) 5 (7.5) 0 (0.0) 0 (0.0)
 Community-acquired sepsis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Nosocomial-acquired sepsis 4 (3.2) 4 (6.0) 0 (0.0) 0 (0.0)
 Gastroenteritis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Intracranial hemorrhage 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Necrotizing enterocolitis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Acute interstitial pneumonitis (noninfective) 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Sepsis 3 (2.4) 2 (3.0) 0 (0.0) 1 (4.4)
 Sepsis (all) 3 (2.4) 2 (3.0) 0 (0.0) 1 (4.4)
  Nosocomial sepsis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Other Group Id: 9 (7.1) 3 (4.5) 5 (13.5) 1 (4.4)
 Community-acquired pneumonia 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Nosocomial-acquired sepsis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Pulmonary tuberculosis 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 Meningitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Encephalitis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Viral hepatitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Acute hepatic failure 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
Group II (noncommunicable diseases): 46 (36.2) 22 (32.8) 10 (27.0) 14 (60.9)
Congenital anomalies 24 (18.9) 17 (25.4) 6 (16.2) 1 (4.4)
 Community-acquired pneumonia 9 (7.1) 6 (10.0) 3 (8.1) 0 (0.0)
 Nosocomial-acquired pneumoniae 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Community-acquired sepsis 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Nosocomial-acquired sepsis 3 (2.4) 2 (3.0) 1 (2.7) 0 (0.0)
 Meningitis (nosocomial) 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Congenital malformation (tetralogy of Fallot) 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Gastrointestinal hemorrhage 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 Hemorrhage, lung 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Congestive heart failuref 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Aspiration pneumonitis 2 (1.6) 0 (0.0) 1 (2.7) 1 (4.4)
Other Group II: 22 (17.3) 5 (7.5) 4 (10.8) 13 (56.5)
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organisms implicated in community-acquired pneumonia 
deaths included K.  pneumoniae (15.6% [n  =  5]), cytomegalo-
virus (CMV; 15.6% [n = 5]), influenza virus (12.5% [n = 4]), and 
S. pneumoniae (12.5% [n = 4]). Forty percent (n = 2/5) of CMV 
pneumonitis– and 25% (n = 1/4) of pneumococcal pneumonia–
attributed deaths were in HIV-infected children.
Klebsiella pneumoniae was the commonest (66.7% [n = 8/12]) 
pathogen causing hospital-acquired pneumonia deaths, and all 
cases had a noninfectious underlying CoD. Seventy-one percent 
(n = 17/24) of the sepsis-related deaths were hospital-acquired, 
most commonly due to Acinetobacter baumannii (47.1% 
[n = 8/17]), K. pneumoniae (35.3% [n = 6/17]), and S. aureus 
(17.6% [n = 3/17]). Among the 7 community-acquired sepsis 
deaths, E. coli accounted for 57.1% (n = 4/7) of cases and S. au-
reus for 14.3% (n = 1/7); no pathogen was identified in 2 cases 
(Table 4).
Of the 6 deaths due to meningitis as the immediate cause, 
4 were community-acquired (S.  pneumoniae; Neisseria 
meningitidis and S.  pneumoniae coinfection; E.  coli; and 
Mycobacterium tuberculosis); and 2 hospital-acquired cases 
were due to A.  baumannii and Candida albicans coinfection 
(n = 1) and E. coli (n = 1).
DISCUSSION
This pilot study demonstrates the value of MITS, interpreted 
with antemortem clinical data, in attributing highly specific 
causes of death in an LMIC setting where under-5 mortality 
rate (per 1000 live births) was estimated to be 53 in 2013 (un-
published data); compared to the national estimate of 42 per 
1000 in 2015 [2]. The DeCoDe panel, with generally high level 
of confidence, attributed an underlying and immediate CoD in 
nearly all (99%) cases. Furthermore, for deaths associated with 
Global Burden of Disease Categorya Total (N = 127) Infants (n = 67) Children (n = 37) Older Children (n = 23)
 Community-acquired pneumonia 4 (3.2) 2 (3.0) 0 (0.0) 2 (8.7)
 Nosocomial-acquired pneumonia 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Nosocomial-acquired sepsis 2 (1.6) 0 (0.0) 1 (2.7) 1 (4.4)
 Pulmonary mucormycosis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Community-acquired meningitis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Nosocomial-acquired meningitis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Intracranial abscess 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Status epilepticus 1 (0.8) 0 (0. 0) 0 (0.0) 1 (4.4)
 Pulmonary embolism 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Heart failure 2 (1.6) 0 (0.0) 2 (5.4) 0 (0.0)
 Cerebral infarction 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Bronchiolitis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Acute respiratory distress syndrome 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Acute hepatic failure 2 (1.6) 1 (1.5) 0 (0.0) 1 (4.4)
 Kidney failure 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Misadventure during surgical/medical care 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
Group III (injuries): 10 (7.9) 1 (1.5) 6 (16.2) 3 (13.0)
Injuries 10 (7.9) 1 (1.5) 6 (16.2) 3 (13.0)
 Nosocomial-acquired pneumoniag 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Community-acquired sepsis 1 (0.8) 0 (0.0) 1 (2.7) 1 (4.4)
 Nosocomial-acquired sepsis 3 (2.4) 0 (0.0) 2 (5.4) 1 (4.4)
  Acute hepatic failure 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
  Asphyxiation 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
  Poisoning 2 (1.6) 1 (1.5) 0 (0.0) 1 (4.4)
  Drowning 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
Ill defined 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Data are presented as No. (%). Main row headings indicate the underlying cause of death, with immediate causes of death below.
Abbreviation: HIV, human immunodeficiency virus. 
aCategorized according to the United Nations Inter-agency Group on Child Mortality Estimation classification categories [12].
bOne pneumonia case had HIV lymphoid interstitial pneumonitis as a coimmediate cause of death.
cThis case of rotavirus gastroenteritis also had a pneumonia as a coimmediate cause of death.
dThe underlying conditions in infants included neonatal jaundice from other hepatocellular damage (n = 1), pneumocystosis (n = 1), and tuberculosis (n = 1). The underlying conditions in 
children included hepatitis A with coma (n = 2), protein energy malnutrition, unspecified (n = 1), and tuberculosis (n = 2). The underlying condition in older children included chickenpox 
(varicella) (n = 1).
eOne case of nosocomial Pseudomonas pneumonia also had nosocomial Escherichia coli meningitis as a coimmediate cause of death; the immediate cause of death in this case is recorded 
as meningitis.
fThis case of congestive heart failure also had congenital hypoplasia and dysplasia of the lung as a coimmediate cause of death.
gThis case of nosocomial Staphylococcus aureus pneumonia also had nosocomial disseminated herpes simplex virus infection as a coimmediate cause of death.
Table 2. Continued
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Table 3. Underlying Cause of Death Categories and Specific Underlying Cause of Death Attribution in Infants (0–11 Months of Age), Children (12–59 
Months of Age), and Older Children (60 Months–14 Years of Age)
Global Burden of Disease Category
Total Infants Children Older Children
(N = 127) (n = 67) (n = 37) (n = 23)
Group I (communicable, maternal, perinatal, and nutritional conditions)a: 70 (55.1) 43 (64.2) 21 (56.8) 6 (26.1)
Acute respiratory infections 10 (7.9) 4 (6.0) 6 (16.2) 0 (0.0)
 Pneumonia 9 (7.1) 3 (4.5) 6 (16.2) 0 (0.0)
 Acute bronchiolitis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Birth asphyxia and trauma 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 Birth asphyxia, unspecified 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
Diarrhea 11 (8.7) 6 (9.0) 4 (10.8) 1 (4.4)
HIV/AIDS 16 (12.6) 9 (13.4) 4 (10.8) 3 (13.0)
 HIV disease 15 (11.8) 9 (13.4) 3 (8.1) 3 (13.0)
 HIV disease resulting in wasting syndrome 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Meningitis/encephalitis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Sepsis 3 (2.4) 2 (3.0) 0 (0.0) 1 (4.4)
Prematurity complications 18 (14.2) 18 (26.9) 0 (0.0) 0 (0.0)
Other Group I: 9 (7.1) 3 (4.5) 5 (13.5) 1 (4.4)
 Congenital rubella syndrome 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Chickenpox (varicella) 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Hepatitis A with coma 2 (1.6) 0 (0.0) 2 (5.4) 0 (0.0)
 Neonatal jaundice from other hepatocellular damage 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Pneumocystosis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Protein energy malnutrition, unspecified 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Tuberculosis 3 (2.4) 1 (1.5) 2 (5.4) 0 (0.0)
Group II (noncommunicable diseases)b: 46 (36.2) 22 (32.8) 10 (27.0) 14 (60.9)
Congenital anomalies 24 (18.9) 17 (25.4) 6 (16.2) 1 (4.4)
 Cardiovascular system abnormalitiesc 4 (3.1) 2 (3.0) 2 (5.4) 0 (0.0)
 Charge syndrome 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Chromosomal abnormality, unspecified 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Congenital hydrocephalus 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Congenital malformation syndromes predominantly affecting facial appearance 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Down syndrome, unspecified 6 (4.7) 5 (7.5) 1 (2.7) 0 (0.0)
 GI tract abnormalitiesd 9 (7.1) 7 (10.4) 2 (5.4) 0 (0.0)
 Spina bifida with hydrocephalus, unspecified 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Other Group II: 22 (17.3) 5 (7.5) 4 (10.8) 13 (56.5)
 Cerebral infarction 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Cerebral palsy 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Chronic kidney disease 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Coagulation defect (other) 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Fanconi anemia 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Epilepsy 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Galactosemia 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Inflammatory liver disease, unspecified 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Kidney failure, unspecified 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Malignanciese 9 (7.1) 2 (3.0) 2 (5.4) 5 (21.7)
 Mastoiditis, unspecified 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Metabolic disorder, unspecified 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Parvovirus cardiomyopathy 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Group III (injuries)f: 10 (7.9) 1 (1.5) 6 (16.2) 3 (13.0)
Injuries 10 (7.9) 1 (1.5) 6 (16.2) 3 (13.0)
 Asphyxiation 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Burns 4 (3.1) 0 (0.0) 4 (10.8) 0 (0.0)
 Drowning 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Motor vehicle accident (pedestrian) 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Organophosphate poisoning 2 (1.6) 0 (0.0) 1 (2.7) 1 (4.4)
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infection, a specific pathogen was identified in 96% of cases. 
Elucidating such granular information on the causes of death 
could be extremely useful for planning and prioritizing future 
interventions aimed to reduce childhood mortality, even when 
the underlying cause itself might not be preventable (eg, pre-
mature birth).
Notably, this pilot, proof-of-concept study was undertaken 
as a prelude to the multicountry Child Health and Mortality 
Prevention Surveillance (CHAMPS) program to establish the 
acceptability and added value of MITS in providing granular 
detail on the causes of childhood death [13]. The leading un-
derlying CoD among our study population were classified 
under UN-IGME group I, the most common of which were 
prematurity (28%), HIV/AIDS (20%), diarrheal disease (16%), 
and acute respiratory infections (16%). The respective national 
estimates for these conditions as underlying cause of death 
among South African children aged 1–59 months in 2015 were 
0.7%, 1.7%, 14.5%, and 12.6%, respectively [14, 15]. Caveats 
of comparing our study results to the national estimates on 
CoD include that deaths investigated in our study excluded 
deaths not presenting or occurring at the facility, as well as 
biases introduced from the phasing-in of enrollment in the dif-
ferent nonmedical wards at the hospital during the course of 
the study.
Figure 2. Percentage of deaths based on the United Nations Inter-agency Group for Child Mortality Estimation underlying cause of death categories [12] in children aged 
1 month to 14 years in Soweto, South Africa. *Other underlying causes of death include sepsis, birth asphyxia and trauma, ill defined, meningitis/encephalitis. Abbreviation: 
HIV, human immunodeficiency virus.
Global Burden of Disease Category
Total Infants Children Older Children
(N = 127) (n = 67) (n = 37) (n = 23)
 Poisoning, drugs 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Ill definedg 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Data are presented as No. (%). Main row headings indicate the underlying cause of death, with immediate causes of death below.
Abbreviations: GI, gastrointestinal; HIV, human immunodeficiency virus.
aCommunicable, maternal, perinatal, and nutritional conditions includes those conditions whose International Classification of Diseases, Tenth Revision (ICD-10) code is among the following: 
A00–B99, D50–D53, D64.9, E00–E02, E40–E64, G00–G09, H65–H66, J00–J22, J85, N30, N34, N390, N70–N73, O00–P96, U04 [12].
bNoncommunicable conditions are those conditions whose ICD-10 code falls into the any of the following codes: C00–C97, D00–D48, D55–D64 (exclude D64.9), D65–D89, E03–E34, 
E65–E88, F01–F99, G10–G98, H00–H61, H68–H93, I00–I99, J30–J84, J86–J98, K00–K92, L00–L98, M00–M99, N00–N28, N31–N32, N35–N64 (exclude N39.0), N75–N98, Q00–Q99 [12].
cCardiovascular system abnormalities included 1 case each of tetralogy of Fallot (infant), discordant ventriculoarterial connection (child), hypoplasia of aorta (child) and congenital malforma-
tion of the heart, unspecified (infant).
dThe GI tract abnormalities included 3 cases of atresia of bile ducts; 2 cases of congenital absence, atresia and stenosis of jejunum; and 1 case each of gastroschisis, Hirschsprung disease, 
congenital absence, atresia and stenosis of anus without fistula, and congenital absence, atresia and stenosis of duodenum. All these abnormalities were in the infant group except 2 cases 
of atresia of bile ducts (child).
eThe malignancies identified included 2 cases each of acute lymphoblastic leukemia (1 child and 1 older child) and acute myeloblastic leukemia (1 child and 1 older child); and 1 case each 
of benign neoplasm of unspecified adrenal gland (older child); Hodgkin lymphoma, unspecified (older child); non-Hodgkin lymphoma, unspecified (older child); Burkitt lymphoma (older child) 
and malignant neoplasm of brain, unspecified (infant).
fGroup III category includes all conditions whose ICD-10 code is included in V01–Y89 [12].
gIll-defined refers to a cause of death which could not be determined using the available evidence.
Table 2. Continued
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Figure 3. Underlying causes of death according to the United Nations Inter-agency Group for Child Mortality Estimation global burden of disease categories [12] and the 
proportion of the infections as the immediate cause of death (CoD) for the given underlying CoD categories. **Other immediate CoD (excluding pneumonia, sepsis, meningitis, 
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/69/Supplem
ent_4/S361/5584381 by guest on 17 O
ctober 2019
S370 • cid 2019:69 (Suppl 4) • Chawana et al
Consequently, differences in the percentage of deaths at-
tributed to prematurity and HIV/AIDS as the underlying CoD 
in our study, compared with the national modeled estimates, 
could be due to biased case enrollment in our study. Alternately, 
it could be reflective of inaccuracies in the current modeling 
approaches of CoD attribution. Interestingly, however, the pro-
portion of deaths attributed to diarrhea and acute respiratory 
infections as an underlying cause in our study mirrored those 
of the national estimates [1, 15]. Also, the percentage of deaths 
attributed to meningitis (1.6%) as an underlying cause in our 
study was similar to national estimates (1.5%), whereas the re-
spective figure for sepsis (2.4% in our study) as an underlying 
cause was higher than the national estimate (0.2%) [15].
Despite the above study limitation, our findings provide de-
tailed insight into the specific causes of death, which would 
otherwise mainly have been analyzed at the syndromic level. 
This included the dominant role of infections as either the im-
mediate or underlying CoD in children (78%), with specifically 
identified preventable or treatable organisms contributing to 
94% of HIV-related deaths and 90% of pneumonia deaths. The 
role of infections reflected here excludes those contributing to 
death as antecedent CoD, and their overall contribution is likely 
to be even greater when antecedent morbid conditions are con-
sidered. Also, notably, only a single death was attributed to se-
vere malnutrition as the underlying cause, although 62% of the 
children who died were categorized as malnourished.
In our setting where PCV was introduced into the public im-
munization program in 2009, RSV was the commonest path-
ogen implicated in respiratory deaths, albeit a limited number 
of pneumonia cases. This included deaths occurring in prema-
turely born infants, and children with underlying neoplasms 
and congenital malformations. Without postmortem investiga-
tion of these cases, the role of RSV and other pathogens impli-
cated in pneumonia-associated childhood deaths in our study 
would be underappreciated.
Significant progress has occurred in reducing mother-to-child 
HIV transmission in South Africa, as well as providing antiretro-
viral treatment to all HIV-infected children upon their diagnosis 
[16, 17]. Nonetheless, we observed pneumonia from P.  jirovecii 
(n = 6) and CMV (n = 5) as important causes of death in these 
children, similar to observations before antiretroviral treatment 
was standard of care in settings such as ours [18]. This observa-
tion suggests deficiencies in the current HIV treatment program 
in South Africa, where death from preventable causes such as 
P. jirovecii pneumonia is still prevalent in HIV-infected children. 
The findings indicate the utility of MITS in prompting a review of 
recommendations and practices to avoid these preventable deaths.
Analysis of the immediate CoD in our study also highlights 
the contribution of sepsis, which would largely be missed if 
focusing only on the underlying CoD [19]. Considering that 
death from sepsis is treatable, knowledge of the commonly im-
plicated pathogens as revealed by MITS could inform empiric 
antibiotic therapy and sensitize physicians to their important 
role in childhood death, including the role of hospital-acquired 
infections. In developing countries, Klebsiella species and 
S.  aureus have been attributed as important pathogens of 
hospital-acquired sepsis in infants [20–22]. Our study identi-
fied multidrug-resistant (data not shown) A. baumannii as the 
dominant (47.1%) pathogen causing hospital-acquired sepsis. 
The emerging dominance of multidrug-resistant Klebsiella spe-
cies and A. baumannii infections necessitates a review of em-
piric treatment of hospital-acquired infections in settings such 
as ours [23–27].
Congenital malformations (22.1%) were the leading under-
lying CoD among children 1–59 months of age (group II); the 
proportion is 11-fold higher than national estimates (2%) [15]. 
The difference might reflect biases in enrollment in our study 
or, conversely, underascertainment of underlying congenital ab-
normalities in current CoD modeling exercises. Nevertheless, 
MITS provided further insight that the majority of deaths in 
these children were also from treatable or preventable infec-
tions (73.9%), with only 21.7% of the deaths in this group at-
tributed directly to the underlying malformation.
Although MITS provided insight into the causal pathway of 
death in most cases, it might be of limited utility in attributing 
the underlying CoD in noncommunicable disease such as oc-
cult congenital malformations, which we mainly diagnosed 
based on antemortem clinical information. This highlights the 
need for a holistic approach in using all available information 
for fully characterizing the CoD in children. Another limitation 
of MITS, which systematically samples predefined anatomical 
regions, is that focal abnormalities could be missed. Also, al-
though we used molecular assays for identifying some organ-
isms, the interpretation thereof could be controversial in the 
absence of validating the significance of their presence. This 
was partly addressed in our study by interpreting the finding 
from the molecular and microbial culture tests, together with 
the clinical and histopathological results.
In conclusion, our pilot demonstrated that almost two-
thirds of screened parents approached for performing MITS 
on their deceased children consented to study participation. 
Furthermore, despite the study limitations, including the gen-
eralizability of the study findings, we demonstrate the utility of 
MITS in contributing to a granular understanding of the causal 
and diarrhea) includes other circulatory, hepatic failure, pulmonary tuberculosis, encephalitis, aspiration pneumonia, gastrointestinal hemorrhage, poisoning, hepatitis, pul-
monary mucormycosis, hyperosmolality, intracranial abscess, status epilepticus, pulmonary embolism, acute respiratory distress syndrome, acute interstitial pneumonitis, 
kidney failure, necrotizing enterocolitis, tetralogy of Fallot, hemorrhage from respiratory passage, sudden infant death syndrome, asphyxiation, drowning, and complications 
during surgery. Abbreviations: acq, acquired; HIV, human immunodeficiency virus.
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Table 4. Pathogens Identified in Children in Whom the Immediate or Underlying Cause of Death Was Infection Related, Stratified by Disease Syndrome
Diagnosis and Pathogen Overall (N = 127) <12 mo (n = 67) 12–59 mo (n = 37) ≥60 mo (n = 23)
Community-associated pneumoniaa 32 (25.2) 20 (29.9) 10 (27.0) 2 (8.7)
 RSV 7 (5.5) 7 (10.5) 0 (0.0) 0 (0.0)
 Pneumocystis jirovecii 6 (4.7) 6 (9.0) 0 (0.0) 0 (0.0)
 CMV 5 (3.9) 5 (7.5) 0 (0.0) 0 (0.0)
 Klebsiella pneumoniae 5 (3.9) 3 (4.5) 2 (5.4) 0 (0.0)
 Influenza virus 4 (3.1) 1 (1.5) 2 (5.4) 1 (4.4)
 Streptococcus pneumoniae 4 (3.1) 0 (0.0) 4 (10.8) 0 (0.0)
 Moraxella catarrhalis 3 (2.4) 1 (1.5) 2 (5.4) 0 (0.0)
 Haemophilus influenzae 3 (2.4) 0 (0.0) 3 (8.1) 0 (0.0)
  Bordetella pertussis 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
 Pseudomonas aeruginosa 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 Staphylococcus aureus 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.0)
 HMPV 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Streptococcus spp (other) 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Unspecified 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
Nosocomial pneumoniab 12 (9.4) 9 (13.4) 3 (8.1) 0 (0.0)
 K. pneumoniae 8 (6.3) 6 (9.0) 2 (5.4) 0 (0.0)
 S. aureus 2 (1.6) 1 (1.5) 1 (2.7) 0 (0.00)
 Acinetobacter baumannii 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 HMPV 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 P. aeruginosa 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 RSV 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Community-associated sepsis 7 (5.5) 4 (6.0) 1 (2.7) 2 (8.7)
 Escherichia coli 4 (3.1) 2 (3.0) 1 (2.7) 1 (4.4)
 S. aureus 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Unspecified 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
Nosocomial sepsisc 17 (13.4) 9 (13.4) 5 (13.5) 3 (13.1)
 A. baumannii 8 (6.3) 5 (7.5) 2 (5.4) 1 (4.4)
 K. pneumoniae 6 (4.7) 3 (4.5) 2 (5.4) 1 (4.4)
 S. aureus 3 (2.4) 1 (1.5) 2 (5.4) 0 (0.0)
 E. coli 2 (1.6) 2 (3.0) 0 (0.00) 0 (0.0)
 Candida parapsilosis 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Clostridium spp 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Enterococcus faecalis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 P. aeruginosa 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Gastroenteritis 14 (11.0) 8 (11.9) 5 (13.5) 1 (4.4)
 Salmonella 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
 Enteroinvasive E. coli/Shigellad 4 (3.1) 1 (1.5) 2 (5.4) 1 (4.4)
 Rotavirus enteritise 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Norovirus 2 (1.6) 2 (3.0) 0 (0.00) 0 (0.00)
 No pathogen attributed 6 (4.7) 4 (6.0) 2 (5.4) 0 (0.0)
Community-associated meningitisf 4 (3.1) 0 (0.0) 2 (5.4) 2 (8.7)
 S. pneumoniae 2 (1.6) 0 (0.0) 1 (2.7) 1 (4.4)
 E. coli 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Neisseria meningitidis 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Mycobacterium tuberculosis 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
Nosocomial meningitisg 2 (1.6) 1 (1.5) 0 (0.0) 1 (4.4)
 A. baumannii 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 Candida albicans 1 (0.8) 0 (0.0) 0 (0.0) 1 (4.4)
 E. coli 1 (0.8) 1 (1.5) 0 (0.0) 0 (0.0)
Other infection 4 (3.1) 3 (34.5) 1 (2.7) 0 (0.0)
 CMVh 2 (1.6) 2 (3.0) 0 (0.0) 0 (0.0)
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pathway of death in children. Future studies, such as CHAMPS 
[13], which are designed to be more generalizable to the studied 
populations, would help inform the prioritization of interven-
tions and research that is required toward achieving the UN 
Sustainable Development Goal 3.2 target of reducing under-5 
childhood death rates (per 1000 live births) from 39.1 in 2017 
to 25 by 2030.
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Supplementary materials are available at Clinical Infectious Diseases online. 
Consisting of data provided by the authors to benefit the reader, the posted 
materials are not copyedited and are the sole responsibility of the authors, 
so questions or comments should be addressed to the corresponding author.
Notes
Acknowledgments. The authors acknowledge the following patho-
logists for their contribution to undertaking diagnostic histopathology 
investigations: Dr S.  Pather, Dr R.  Mohanlal, Dr E.  van den Berg, Dr 
R. Wadee, and Ms M. Suleman, all from the National Health Laboratory 
Service Department of Anatomical Pathology, Faculty of Health Sciences, 
University of the Witwatersrand. The authors acknowledge the important 
contribution of the Determining Cause of Death (DeCoDe) panel (spe-
ciality in parenthesis) that was chaired by Scott Dowell (epidemiologist, 
paediatrician) and Christopher Wilson (infectious diseases, pediatrician). 
Other DeCoDe panel members were Quique Bassat (infectious diseases, 
pediatrician), Dianna Blau (microbiology), Robert Breiman (epidemiology, 
infectious diseases, physician), Daniel Chandramohan (epidemiology, 
World Health Organization International Classification of Diseases coding 
specialist), Richard Chawana (physician), Kevin Clarke (microbiology), 
Martin Hale (pathology), Penny Heaton (physician), Eric Houpt (micro-
biology, infectious disease, physician), Aggrey Igunza (study clinician), 
Grace Irimu (pediatrician), Reinhard Kaiser (epidemiology, physician), 
Nicholas Kassebaum (microbiology), Keith Klugman (microbiology, infec-
tious diseases, physician), Karen Kotloff (infectious diseases, pediatrician), 
Shabir Madhi (infectious diseases, pediatrician), Kim Mulholland (infec-
tious diseases, epidemiology, pediatrician), Jaume Ordi (pathology), Robert 
Pattinson (obstetrician), Rebecca Philipsborn (pediatrician), Pratima 
Raghunathan (epidemiology), Milagritos Tapia (infectious diseases, pedia-
trician). Allan Taylor (epidemiology, pediatrician), Sherif Zaki (pathology).
Disclaimer. The findings and conclusions in this report are those of 
the author(s) and do not necessarily represent the official position of the 
Centers for Disease Control and Prevention. The funder played no role in 
the study design, data collection and analyses, preparation, or approval of 
this manuscript. The Bill & Melinda Gates Foundation staff participated in 
the DeCoDe panel and the program officer (Scott Dowell) was provided 
the opportunity to review a preliminary version of this manuscript for fac-
tual accuracy, but the authors are solely responsible for final content and 
interpretation.
Financial support. This work was supported by the Bill & Melinda 
Gates Foundation (award number OPP1101764).
Supplement sponsorship. This supplement is sponsored by the Emory 
Global Health Institute and the Bill & Melinda Gates Foundation.
Potential conflicts of interest. S. A. M. has received grants from 
the Bill & Melinda Gates Foundation, Pfizer, Glaxo Smith Kline, Biovac, 
Novavax, and Sanofi Pasteur; and honoraria from The Bill & Melinda Gates 
Foundation. All other authors report no potential conflicts of interest. 
All authors have submitted the ICMJE Form for Disclosure of Potential 
Conflicts of Interest. Conflicts that the editors consider relevant to the con-
tent of the manuscript have been disclosed.
References
1. Hug L, Sharrow D, Sun Y, Marcusanu A, You D. Levels and trends in child mor-
tality: report 2017, estimates developed by the UN Inter-agency Group for Child 
Mortality Estimation. New York: United Nations Children’s Fund, 2017.
2. Liu L, Hill K, Oza S, et al. Levels and causes of mortality under age five years. 
In: Black R, Laxminarayan R, Temmerman M, Walker N, eds. Reproductive, ma-
ternal, newborn, and child health: disease control priorities. 3rd ed. Washington, 
DC: International Bank for Reconstruction and Development/World Bank, 2016.
3. Jha P. Reliable direct measurement of causes of death in low- and middle-income 
countries. BMC Med 2014; 12:19.
4. Wang H, Bhutta ZA, Coates MM, et al. Global, regional, national, and selected 
subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980–
2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet 
2016; 388:1725–74.
5. Kang X, Cos T, Guizani M, Cannie MM, Segers V, Jani JC. Parental acceptance of 
minimally invasive fetal and neonatal autopsy compared with conventional au-
topsy. Prenat Diagn 2014; 34:1106–10.
6. Maixenchs M, Anselmo R, Zielinski-Gutiérrez E, et al. Willingness to know the 
cause of death and hypothetical acceptability of the minimally invasive autopsy in 
six diverse African and Asian settings: a mixed methods socio-behavioural study. 
PLoS Med 2016; 13:e1002172.
7. Bassat Q, Castillo P, Martínez MJ, et al. Validity of a minimally invasive autopsy 
tool for cause of death determination in pediatric deaths in Mozambique: an ob-
servational study. PLoS Med 2017; 14:e1002317.
8. Madhi  SA, Pathirana  J, Baillie  V, et  al. Unravelling specific causes of neonatal 
mortality using minimally invasive tissue sampling: an observational study. Clin 
Infect Dis 2019; 69(Suppl 4):S342–50.
9. Madhi SA, Bamford L, Ngcobo N. Effectiveness of pneumococcal conjugate vac-
cine and rotavirus vaccine introduction into the South African public immunisa-
tion programme. S Afr Med J 2014; 104:228–34.
10. World Health Organization. International statistical classification of diseases and 
related health problems, tenth revision. 5th ed. Geneva, Switzerland: WHO Press, 
2016.
Diagnosis and Pathogen Overall (N = 127) <12 mo (n = 67) 12–59 mo (n = 37) ≥60 mo (n = 23)
 HSV (nosocomial) 1 (0.8) 0 (0.0) 1 (2.7) 0 (0.0)
 Rubella (congenital) 1 (0.8) 1 (1.5) 0 (0.00) 0 (0.00)
Data are presented as No. (%).
Abbreviations: CMV, cytomegalovirus; HMPV, human metapneumovirus; HSV, herpes simplex virus; RSV, respiratory syncytial virus.
aThe total is less than the column sum because of the following coinfections: H. influenzae, S. pneumoniae, and influenza A virus (underlying); K. pneumoniae and M. catarrhalis; P. jirovecii 
and M. catarrhalis; P. jiroveci and CMV; S. aureus (methicillin resistant) and other Streptococcus spp; P. jiroveci and RSV; H. influenzae and S. pneumoniae; K. pneumoniae and influenza C 
virus; P. aeruginosa and S. pneumoniae; K. pneumoniae and RSV; H. influenzae and M. catarrhalis.
bThe total is less than the column sum because of the following coinfections attributed to pneumonia cases: K. pneumoniae and HMPV; K. pneumoniae and RSV.
cThe total is less than the column sum because of the following coinfections among sepsis cases: S. aureus and P. aeruginosa; A. baumannii sepsis and S. aureus (methicillin resistant); 
K. pneumoniae and A. baumannii; A. baumannii and E. coli; K. pneumoniae and E. faecalis; A. baumannii and S. aureus; A. baumannii and C. parapsilosis.
dOne case of enteroinvasive E. coli/Shigella gastroenteritis as underlying cause of death (CoD) had E. coli sepsis as the immediate CoD.
eThis case had of rotavirus gastroenteritis also had influenza virus pneumonia as a coimmediate CoD.
fThe total is less than the column sum because of the following coinfections: S. pneumoniae meningitis and N. meningitidis meningitis.
gThe total is less than the column sum because of 1 case with A. baumannii and C. albicans meningitis.
hAlthough the 2 cases of disseminated CMV were community-acquired, they had coinfections with nosocomial A. baumannii sepsis and nosocomial K. pneumoniae sepsis.
Table 4. Continued
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/69/Supplem
ent_4/S361/5584381 by guest on 17 O
ctober 2019
Potential of MITS in South Africa • cid 2019:69 (Suppl 4) • S373
11. You D, Hug L, Chen Y, Newby H, Wardlaw T. Levels and trends in child mor-
tality. In: United Nations Inter-agency Group for Child Mortality Estimation 
(UN-IGME). New York: United Nations Children’s Fund, 2014.
12. Hogan D, Chu Y, Liu L, Oza S. WHO methods and data sources for child causes 
of death 2000-2016. Geneva, Switzerland: WHO, 2018.
13. Raghunathan  PL, Madhi  SA, Breiman  RF. Illuminating child mortality: 
discovering why children die. Clin Infect Dis 2019; 69(Suppl 4):S257–9.
14. Ntuli ST, Malangu N, Alberts M. Causes of deaths in children under-five years old 
at a tertiary hospital in Limpopo province of South Africa. Glob J Health Sci 2013; 
5:95–100.
15. Statistics South Africa. Mortality and causes of death in South Africa, 2015: find-
ings from death notification. Pretoria: Statistics South Africa, 2015.
16. National Department of Health. National consolidated guidelines for the preven-
tion of mother-to-child transmission of HIV (PMTCT) and the management of 
HIV in children, adolescents and adults. Pretoria, South Africa: Department of 
Health, 2015.
17. National Department of Health. Guidelines for maternity care in South Africa. 
Pretoria, South Africa: Department of Heath, 2015.
18. Bates  M, Mudenda  V, Mwaba  P, Zumla  A. Deaths due to respiratory tract in-
fections in Africa: a review of autopsy studies. Curr Opin Pulm Med 2013; 
19:229–37.
19. Lozano R, Fullman N, Abate D, et al. Measuring progress from 1990 to 2017 and 
projecting attainment to 2030 of the health-related Sustainable Development 
Goals for 195 countries and territories: a systematic analysis for the Global 
Burden of Disease Study 2017. Lancet 2018; 392:2091–138.
20. Stoll BJ. The global impact of neonatal infection. Clin Perinatol 1997; 24:1–21.
21. Bacterial etiology of serious infections in young infants in developing countries: 
results of a multicenter study. The WHO Young Infants Study Group. Pediatr 
Infect Dis J 1999; 18:S17–22.
22. Newton O, English M. Young infant sepsis: aetiology, antibiotic susceptibility and 
clinical signs. Trans R Soc Trop Med Hyg 2007; 101:959–66.
23. Al Jarousha AM, El Jadba AH, Al Afifi AS, El Qouqa IA. Nosocomial multidrug-
resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, 
Palestine. Int J Infect Dis 2009; 13:623–8.
24. von Dolinger de Brito D, Oliveira EJ, Abdallah VO, da Costa Darini AL, Filho PP. 
An outbreak of Acinetobacter baumannii septicemia in a neonatal intensive care 
unit of a university hospital in Brazil. Braz J Infect Dis 2005; 9:301–9.
25. Hsu  JF, Chu  SM, Lien  R, et  al. Case-control analysis of endemic Acinetobacter 
baumannii bacteremia in the neonatal intensive care unit. Am J Infect Control 
2014; 42:23–7.
26. Chang PY, Hsueh PR, Wu PS, et al. Multidrug-resistant Acinetobacter baumannii 
isolates in pediatric patients of a university hospital in Taiwan. J Microbiol 
Immunol Infect 2007; 40:406–10.
27. Hong  KB, Oh  HS, Song  JS, et  al. Investigation and control of an outbreak of 
imipenem-resistant Acinetobacter baumannii infection in a pediatric intensive 
care unit. Pediatr Infect Dis J 2012; 31:685–90.
D
ow
nloaded from
 https://academ
ic.oup.com
/cid/article-abstract/69/Supplem
ent_4/S361/5584381 by guest on 17 O
ctober 2019
